New AI System Aids Early Detection of Deadly Pancreatic Cancer Cases

A new research has unveiled a novel AI system designed to enhance the detection of the most prevalent type of pancreatic cancer. Identifying pancreatic cancer poses challenges due to the pancreas being obscured by surrounding organs, making tumor identification challenging. Moreover, symptoms rarely manifest in early stages, resulting in diagnoses at advanced stages when the cancer has already spread, diminishing chances of a cure.

To address this, a collaborative effort between MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and Limor Appelbaum from Beth Israel Deaconess Medical Center produced an AI system aimed at predicting the likelihood of an individual developing pancreatic ductal adenocarcinoma (PDAC), the predominant form of the cancer. This AI system, named PRISM, demonstrated superior performance compared to existing diagnostic standards, presenting the potential for future clinical applications in identifying candidates for early screening or testing, ultimately leading to improved outcomes.

The researchers aspired to construct a model capable of forecasting a patient’s risk of PDAC diagnosis within the next six to 18 months, facilitating early detection and treatment. Leveraging existing electronic health records, the PRISM system comprises two AI models. The first model, utilizing artificial neural networks, analyzes patterns in data such as age, medical history, and lab results to calculate a personalized risk score. The second model, employing a simpler algorithm, processes

[…]
Content was cut in order to protect the source.Please visit the source for the rest of the article.